Middletown, DE -- (SBWIRE) -- 08/22/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Exelixis, Inc. (NASDAQ:EXEL), BGC Partners, Inc.(NASDAQ:BGCP), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Shanda Games Limited(ADR) (NASDAQ:GAME)
Exelixis, Inc. (NASDAQ:EXEL) traded on below-normal volume of 1.15 million shares. The stock settled at $5.08 after floating in a range of $5.05 to 5.20. Significantly, its latest price is at a premium of 6.29% to its 200-day moving average price. Its 52-week range has been $4.25 to $5.56; it is trading at a discount of -8.63% to its 52-week high and a premium 19.53% to its 52-week low.
Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds. Cabozantinib is the inhibitor of MET in clinical development and is being evaluated in a development program encompassing multiple cancer indications.
Has EXEL Found The Bottom And Ready To Gain Momentum? Find Out Here
BGC Partners, Inc.(NASDAQ:BGCP) traded down on a volume of 1.14 million, higher than its standard daily volume. Shares have dropped-2.03% to $5.79. Over the last twelve months, the stock has gained 31.89% and faced a worst price of $3.11. The stock has moved down across its 50-day moving average of -4.40%.
BGC Partners, Inc. (BGC) is a global brokerage company primarily servicing the wholesale financial markets, specializing in the brokering of a range of products, including fixed income securities, interest rate swaps, foreign exchange, equities, equity derivatives, credit derivatives, commercial real estate, property derivatives, commodities, futures and structured products. It also provides a range of services,
Has BGCP Found The Bottom and Ready To Move Up? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) settled -2.66% lower at $3.29 on below-normal volume of 1.13 million shares during the last trading day. The most recent price of this stock was at a discount of -70.39% to the 12-month high of $11.11. The last price is at a premium of 0.92% to the 52-week low of $3.26.
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company’s product candidates include MM-398, MM-121, MM-111, MM-302 and MM-151.
Will MACK Get Buyers Even After The Recent Rally? Find Out Here
Shanda Games Limited(ADR) (NASDAQ:GAME) saw its price fall on above-normal volume, as1.10million shares changed hands when compared with its average daily volume of 1.95 million shares. The stock was down -1.99% to $4.44. It has gained over the last 12 months, increasing 26.14% and marked new low $2.68. At the end of recent trade, the stock has moved up across its SMA 200 of 29.36%.
Shanda Games Limited (Shanda Games) is engaged in the development and operation of online games and related businesses in the People’s Republic of China. Some of its online games are also Web games, which the Company categorizes as either massively multiplayer online role-playing games (MMORPGs) or advanced casual games,
Why Should Investors Buy GAME After the Recent Fall? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)